AwardJun 12, 2026, 03:01 AM
Evaxion Wins 2026 Prix Galien UK Award for AI-Immunology™ Platform
AI Summary
Evaxion A/S has been awarded the prestigious 2026 Prix Galien UK Award for Best digital health solution, recognizing its AI-Immunology™ platform. This marks the second time in less than a year that Evaxion has received an award from the Galien Prix Foundation, underscoring the external validation of its AI-Immunology™ platform. The platform leverages artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases.
Key Highlights
- Evaxion awarded the 2026 Prix Galien UK Award for Best digital health solution.
- The award specifically recognizes Evaxion's pioneering AI-Immunology™ platform.
- This marks the second recognition from the Galien Prix Foundation in less than a year.
- Evaxion previously received an award in December 2025 for Best Medical Technology / AI Advances.
- The jury focused on innovation, scientific development, clinical application, utility, and impact on human health.
- The AI-Immunology™ platform develops novel vaccine candidates for cancer and infectious diseases.
Price Impact
More from EVAX